n-methyl-3,4-methylenedioxyamphetamine has been researched along with Anemia, Hemolytic in 1 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goorney, BP | 1 |
| Scholes, P | 1 |
1 other study available for n-methyl-3,4-methylenedioxyamphetamine and Anemia, Hemolytic
| Article | Year |
|---|---|
Transient haemolytic anaemia due to ecstasy in a patient on HAART.
Topics: Administration, Oral; Adult; Anemia, Hemolytic; Antiretroviral Therapy, Highly Active; Drug Interact | 2002 |